Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Zetomipzomib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kezar Life Reports Positive Results from PORTOLA Ph 2 Trial
    Kezar Life Reports Positive Results from PORTOLA Ph 2 Trial

    25 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250325918238/en/Kezar-Life-Sciences-Announces-Positive-Topline-Results-from-the-PORTOLA-Phase-2a-Trial-Evaluating-Zetomipzomib-for-the-Treatment-of-Patients-with-Autoimmune-Hepatitis-AIH-and-Reports-Fourth-Quarter-and-Year-End-2024-Financial-Results

    BUSINESSWIRE
    25 Mar 2025
    Share Share
    Kezar Life Sciences to Present PORTOLA Phase 2a Trial Results
    Kezar Life Sciences to Present PORTOLA Phase 2a Trial Results

    24 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250324687575/en/Kezar-Life-Sciences-to-Present-Topline-Results-from-the-PORTOLA-Phase-2a-Trial-Evaluating-Zetomipzomib-for-the-Treatment-of-Patients-with-Autoimmune-Hepatitis-on-March-25-2025

    BUSINESSWIRE
    24 Mar 2025
    Share Share
    Kezar To Present Zetomipzomib Data In AIH, Lupus Trial Update
    Kezar To Present Zetomipzomib Data In AIH, Lupus Trial Update

    18 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250218398885/en

    BUSINESSWIRE
    18 Feb 2025
    Share Share
    Kezar Life Sciences Reports Positive Portola Trial Safety Review
    Kezar Life Sciences Reports Positive Portola Trial Safety Review

    17 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241017004238/en

    BUSINESSWIRE
    17 Oct 2024
    Share Share
    Kezar halts mid-stage lupus study after four deaths
    Kezar halts mid-stage lupus study after four deaths

    01 Oct 2024

    // Zoey Becker FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/kezar-halts-dosing-and-enrollment-key-lupus-study-following-4-patient-deaths

    Zoey Becker FIERCE BIOTECH
    01 Oct 2024
    Share Share
    Kezar Life Sciences Ends Enrollment In Ph2 Trial For Zetomipzomib
    Kezar Life Sciences Ends Enrollment In Ph2 Trial For Zetomipzomib

    30 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240930482248/en

    BUSINESSWIRE
    30 Sep 2024
    Share Share